Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-110194
Filing Date
2016-03-23
Accepted
2016-03-23 15:07:10
Documents
1
Period of Report
2016-03-21

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 5543
  Complete submission text file 0001209191-16-110194.txt   7091
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Issuer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 9360 TOWNE CENTRE DRIVE SAN DIEGO CA 92121
Business Address
Marshall Paul (Reporting) CIK: 0001383994 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33221 | Film No.: 161523727